In vivo studies with covalent conjugates of cobra venom factor and monoclonal antibodies to human tumors.
In vivo studies with covalent conjugates of cobra venom factor and monoclonal antibodies to human tumors.
复制标题
眼镜蛇毒因子和人类肿瘤单克隆抗体共价缀合物的体内研究。
DOI:
10.1007/978-3-642-70385-0_104
复制
发表时间:
1985
期刊:
影响因子:
--
通讯作者:
Morgan,AC
中科院分区:
文献类型:
--
作者:
Vogel,CW;Wilkie,SD;Morgan,AC
Cobra venom factor (CVF) is a nontoxic glycoprotein withMr ~140 000, obtained from cobra venom. CVF is a functional analog of C3b, the activated form of the third component of complement. Like C3b, CVF forms in serum with factor B of the alternative complement pathway an enzyme, the C3/C5 convertase [1]. The CVFdependent enzyme is very stable and resistant to inactivation by control proteins. Therefore, once the enzyme is formed, it continuously activates C3 and C5.